The most trusted news from Massachusetts

Provided by AGP

Got News to Share?

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on May 11, 2026

ELECTRA AI and Iron Horse Acquisition II Corp. (Nasdaq: IRHO) Release Additional Investor Materials
Rocket Software Completes Acquisition of Vertica, Expanding High-Performance Analytics and AI for Mission-Critical Systems
Rapid7 to Participate in Upcoming Investor Conferences
Disc Medicine to Participate in Upcoming Investor Conferences
维泰瑞隆SARM1抑制剂SIR2501获FDA快速通道资格,用于治疗化疗所致的周围神经病变(CIPN)
維泰瑞隆SARM1抑制劑SIR2501獲FDA快速通道資格,用於治療化療所致的周圍神經病變(CIPN)
Brick Marketing to Present AI Search (SEO) Mastermind Sessions at SMX Advanced Boston
Sironax’s SARM1 Inhibitor SIR2501 Granted FDA Fast Track Designation in Chemotherapy-induced Peripheral Neuropathy (CIPN)
Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates
 Dyne Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
Bicara Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results
Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes
Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Control, 67% Complete Response Rate, and Favorable Safety Profile Observed - Conference Call Scheduled for 8:30am ET

Share us

on your social networks:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.